On January 5, 2026, SAB Biotherapeutics, Inc. appointed Dr. David Zaccardelli and Dr. Rita Jain as Class II directors, effective immediately. This event represents a significant change in management as it involves key leadership appointments, reflecting the company's strategic direction.